.Regeneron is back with lasting follow-up for its own LAG-3 prevention and also PD-1 prevention comb...
.AstraZeneca has actually discussed a very early look at the performance of its own in-house antibod...
.After announcing a phase 3 launch based on favorable midstage outcomes, iTeos and GSK are lastly sh...
.The FDA should be actually even more available and joint to discharge a rise in approvals of rare c...
.It's an uncommonly hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bicara Rehab...
.Atea Pharmaceuticals' antiviral has actually neglected an additional COVID-19 trial, but the biotec...
.Neurocrine Biosciences' mental illness program pivot has actually neglected. The biotech was not ab...
.Sanofi has made a late access to the radioligand party, paying 100 thousand europeans ($ 110 millio...
.After F2G's first attempt to obtain a new training class of antifungal to market was derailed due t...
.Moderna has pledged to reduce R&D costs through $1.1 billion through 2027. The decision to retra...